Updated 45 sec ago
Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says
- Last week Congo had requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile
- The ongoing outbreak is caused by the Bundibugyo species of Ebola, which has β no approved vaccines or treatments
The Democratic Republic βof Congo has been allocated 70,000 doses of Merckβs Ervebo vaccine for Ebola, the World Health Organization said on Thursday, as the country attempts to contain its biggest ever outbreak of the deadly disease.
Here are some details:
Last week Congo had requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile, managed by the International Coordinating Group (ICG) on Vaccine Provision, βaccording to βWHO.
The health agency said βthe β group allocated 70,000 β Ervebo doses for Congo, of which 20,000 shots will be used in a late-stage trial to understand the impact of the vaccine on the Bundibugyo virus.
The ongoing outbreak is caused by the Bundibugyo species of Ebola, which has β no approved vaccines or treatments.
βIt βis not known βwhether Ervebo may be protective against the Bundibugyo virus in βhumans,β WHO said, stressing the importance of βclinical trials to provide important new evidence.
Ervebo is approved to prevent disease caused by the more common Zaire ebolavirus strain.
The number of confirmed βEbola cases in the Democratic Republic of Congo now exceeds 5,000, according β to β government data.
Congoβs 17th Ebola epidemic became the countryβs biggest on record in late July by case count, with the death toll now at 2,378 β surpassing the previous worst outbreak in 2018-2020.
Earlier this week, WHOβs director-general Tedros Ghebreyesus said the Ebola outbreak in eastern Congo remains a global emergency.
The ICG is a partnership between the WHO, the International Federation of the Red Cross and Red Crescent Societies, MΓ©decins Sans Frontieres and UNICEF.
Credit: Source link
Comments are closed.